ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $557,000 | +525.8% | 11,501 | +447.7% | 0.16% | +246.7% |
| Q1 2020 | $89,000 | -63.7% | 2,100 | -69.1% | 0.04% | -29.7% |
| Q3 2019 | $245,000 | +129.0% | 6,798 | +70.0% | 0.06% | +106.5% |
| Q2 2019 | $107,000 | -47.3% | 4,000 | -70.4% | 0.03% | -32.6% |
| Q2 2018 | $203,000 | +10.9% | 13,500 | +70.9% | 0.05% | +2.2% |
| Q1 2018 | $183,000 | +34.6% | 7,900 | +119.4% | 0.04% | +50.0% |
| Q3 2017 | $136,000 | -31.3% | 3,600 | -40.8% | 0.03% | +11.1% |
| Q2 2016 | $198,000 | -69.7% | 6,086 | -69.6% | 0.03% | -77.1% |
| Q1 2015 | $653,000 | – | 20,047 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |